Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Salt Lake City, UT
SEC filing record 1 source field available
Fiscal year end
31 December
RECURSION PHARMACEUTICALS, INC. has filed 958 SEC EDGAR filings since 02 Apr 2014

SEC filing history

Showing 351-375 of 958 matching filings.

Per page
25
Current page
15
4/A

FORM 4/A

Filing date
12 Jul 2024
Reporting date
05 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2024
Reporting date
09 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Jul 2024
Reporting date
09 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
11 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
10 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
09 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
09 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92498

SC 13G

Filing date
08 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Jun 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jun 2024
Reporting date
25 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-264845

424B5

Filing date
27 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-264845

424B5

Filing date
26 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
25 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Jun 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144/A File 001-40323

144/A filing

Filing date
14 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40323

144 filing

Filing date
14 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .